--Walmart Guides For FY 2025 EPS of $2.34-$2.43 on Sales Increase of 3.75%-4.75%-February 2024-www.financetom.com

--Walmart Guides For FY 2025 EPS of $2.34-$2.43 on Sales Increase of 3.75%-4.75%

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Walmart Guides For FY 2025 EPS of $2.34-$2.43 on Sales Increase of 3.75%-4.75%

Aug 15, 2024 4:30 AM

07:06 AM EDT, 08/15/2024 (MT Newswires) --

Price: 71.98, Change: +3.32, Percent Change: +4.84

Previous page： Westrock Coffee Starts Warrant Exchange Offer; Shares Rise Pre-Bell Next page： Atossa Therapeutics Secures New US Patent for Breast Cancer Treatment Endoxifen

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Westrock Coffee Starts Warrant Exchange Offer; Shares Rise Pre-Bell

Aug 29, 2024

09:00 AM EDT, 08/28/2024 (MT Newswires) -- Westrock Coffee ( WEST ) said Wednesday it is offering up to about 5.6 million common shares in exchange for its outstanding public and private placement warrants. The company is offering all warrant holders 0.29 common shares for each outstanding warrant tendered and exchanged under the offer. Westrock Coffee ( WEST ) said...

Atossa Therapeutics Secures New US Patent for Breast Cancer Treatment Endoxifen

Aug 29, 2024

09:12 AM EDT, 08/28/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) said Wednesday that the US Patent and Trademark Office has granted it a new patent covering compositions of endoxifen and an enteric-coating material in which at least 90% of the endoxifen is (Z)-endoxifen. The breast cancer-focused biopharmaceutical company said the patent also covers methods of administering those compositions...

Vaxart Says Preclinical Data Support Potential Vaccine Against HPV-Related Cervical Dysplasia

Aug 29, 2024

09:12 AM EDT, 08/28/2024 (MT Newswires) -- Vaxart ( VXRT ) said Wednesday that preclinical data on its mucosal vaccine platform suggest a potential for treating HPV-related cervical dysplasia. The company said its human papillomavirus, or HPV, vaccine constructs can stimulate an immune response against HPV16 proteins and reduce tumor size in mice, with increased survival rates. The data was...

--Super Micro Computer to Delay Filing Form 10-K for FY 2024

Aug 29, 2024

09:13 AM EDT, 08/28/2024 (MT Newswires) -- Price: 498.44, Change: -49.20, Percent Change: -8.98 ...